Research Article | | Peer-Reviewed

Assessment of Stigma, Violence and Coping Mechanisms Among HIV Infected People Who Inject Drugs in Akwa-Ibom State, Nigeria

Received: 11 March 2024     Accepted: 23 March 2024     Published: 10 May 2024
Views:       Downloads:
Abstract

People who inject drugs (PWIDs) living with HIV face high levels of stigma, violence, and rape due to their risky lifestyles, potentially facilitating the spread of HIV. This study assessed the level and type of stigma and violence among PWIDs attending Heartland Alliance in Akwa Ibom State and their coping mechanisms. This descriptive cross-sectional study of 442 PWIDs receiving care at four one-stop shops in the state was conducted using mixed methods. Quantitative data were collected through pretested structured questionnaires and an adopted stigma scale, administered by trained research assistants using Computer Assisted Personal Interviewer (CAPI). For qualitative data, one focus group discussion (FGD) was held at each site with 8-10 purposively selected PWIDs, and transcripts were analyzed thematically. The study findings reveals that most respondents were male (78%) with a mean age of 32.7±7 years. Pentazocine use was common (52%), and 18% shared needles, with 15% sharing blood after injections among friends. More than half (58%) missed more than one dose of ARVs in the past week. Perceived stigma (59%) was more common than internal stigma (18%), with predictors being student status, non-disclosure of HIV status, and non-adherence to treatment. PWIDs Physical violence (47.5%) and verbal abuse (37.1%) were prevalent among PWIDs. Female PWIDs had a ninefold higher risk of rape. Coping mechanisms included isolation, increased substance use, battle readiness, and positive reframing. Conclusion: PWIDs face significant levels of stigma, violence, and non-adherence, jeopardizing treatment outcomes and perpetuating STI, HIV, and blood-borne infection transmission. Establishing harm-reduction programs is essential to address these vulnerabilities and the consequences associated with drug use.

Published in World Journal of Public Health (Volume 9, Issue 2)
DOI 10.11648/j.wjph.20240902.14
Page(s) 125-143
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

People Who Inject Drugs, Stigma, Violence, Coping Mechanism

References
[1] UNAIDS. “Miles to go: closing gaps, breaking barriers, fighting injustices.” 2018. p. 1–268.
[2] UNAIDS. Blind Spot: Reaching out to men and boys. 2017; 76.
[3] Escudero DJ, Lurie MN, Mayer KH, Weinreb C, King M, Galea S, et al. Acute HIV Infection Transmission Among People Who Inject Drugs in a mature Epidemic Setting. AIDS. 2016; 30: 2537–44.
[4] UNAIDS. THE GAP REPORT: People who inject drugs. 2014.
[5] Onovo A, Kalaiwo AS, Katbi M, Keiser O. Geographical Disparities in HIV Prevalence among Men Who Have Sex with Men and People Who Inject Drugs in Nigeria. Lancet HIV. 2020; 1–23.
[6] UNODC. Drug use in nigeria. 2018.
[7] Ezirim IO, Ogungbemi K, Daniel U, Blanchard J, Ezire O. Evidence from epidemic appraisals in Nigeria. African Eval J. 2015; 3: 1–8.
[8] Veen S van der, Trout C, Cenival M de, Emmanuel G. Opportunities to address the growing “syndemics” of HIV, sexually transmitted infection, stigma, violence and substance abuse among people who inject drugs in Nigeria. 2017.
[9] Awofala AA, Ogundele OE. HIV epidemiology in Nigeria. Saudi J Biol Sci. 2018; 25: 697–703.
[10] Kane JC, Elafros MA, Murray SM, Mitchell EMH, Augustinavicius JL, Causevic S, et al. A scoping review of health-related stigma outcomes for high-burden diseases in low- and middle-income countries. BMC Med. 2019; 17: 1–40.
[11] Drug Policy Alliance. Stigma and People Who Use Drugs. 2009. p. 10001.
[12] ASHM. Stigma and Discrimination around HIV and HCV in Healthcare Settings: Research Report. 2012.
[13] Wood K, Aggleton P. Stigma, Discrimination and Human Rights. 2003.
[14] Nyblade L, Stockton MA, Giger K, Bond V, Ekstrand ML, Lean RM, et al. Stigma in health facilities: why it matters and how we can change it. BMC Med. 2019; 17: 1–15.
[15] Myers B, Petersen Z, Pithey A, Pasche S, Dada S. Barriers to antiretroviral therapy use among people who inject drugs: A systematic review. 2012.
[16] Stringer KL, Mukherjee T, Mccrimmon T, Terlikbayeva A, Primbetovac S, Darisheva M, et al. Attitudes towards people living with HIV and people who inject drugs: A mixed method study of stigmas within harm reduction programs in Kazakhstan. Int J Drug Policy. 2019; 68: 27–36.
[17] Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, et al. HIV among People Who Inject Drugs in the Middle East and North Africa: Systematic Review and Data Synthesis. PLoS Med. 2014; 11: 1–30.
[18] Kharsany ABM, Karim QA. HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities. Open AIDS J. 2016; 10: 34–48.
[19] Sabin K, Zhao J, Maria J, Calleja G, Sheng Y, Arias S. Availability and Quality of Size Estimations of Female Sex Workers, Men Who Have Sex with Men, People Who Inject Drugs and Transgender Women in Low- and Middle- Income Countries. PLoS One. 2016; 11: 1–11.
[20] Monjok E, Smesny A, Essien EJ. HIV/AIDS - Related Stigma and Discrimination in Nigeria: Review of Research Studies and future directions for Prevention Strategies. Afr J Reprod Health. 2010; 13: 21–35.
[21] Ibragimov U, Cooper HL, Haardörfer R, Dunkle KL, Zule WA, Wong FY. Stigmatization of people who inject drugs (PWID) by pharmacists in Tajikistan: sociocultural context and implications for a pharmacy-based prevention approach. Harm Reduct J. 2017; 1–11.
[22] Paquettea CE, Syvertsen JL, Pollini RA. Stigma at Every Turn: Health Services Experiences among People Who Inject Drugs. Int J Drug Policy. 2018; 57: 104–10.
[23] GNP+. The People Living with HIV Stigma Index - Nigeria. 2011.
[24] Rivera A V., DeCuir J, Crawford ND, Amesty S, Lewis CF. Internalized stigma and sterile syringe use among people who inject drugs in New York City, 2010-2012. Drug Alcohol Depend. 2015; 144: 259–64.
[25] Veen S Van Der, Cenival M De, Trout C. Harm reduction guidelines for needle and syringe programs, opioid substitution therapy, prevention and management of opioid overdose with naloxone. 2018.
[26] The Global Fund. Harm reduction for people who use drugs. 2020. p. 1–25.
[27] Harm Reduction International. The Case for a Harm Reduction Decade: Progress, potential and paradigm shifts. 2016.
[28] FHI 360. The Nexus of Gender and HIV among Transgender People in Kenya. 2016.
[29] WHO/World Bank. Women who inject drugs and HIV: addressing specific needs. 2014.
[30] Fischer B. Some notes on the use, concept and socio-political framing of “stigma” focusing on an opioid-related public health crisis. Subst Abus Treat Prev Policy. 2020; 15: 1–7.
[31] Israel UE. Urbanization and Conflict: A Study of Uyo, 1900-2015. African J Hist Archaeol. 2018; 3: 35–49.
[32] Government of Akwa Ibom State of Nigeria. Akwa Ibom State History. 2016.
[33] Jacob A, Akpan P A. Spatial Distribution and Accessibility of Health Facilities in Akwa Ibom State, Nigeria. Ethiop J Environ Stud Manag. 2009; 2: 49–57.
[34] Zeng C, Li L, Hong YA, Zhang H, Babbitt AW, Liu C, et al. A structural equation model of perceived and internalized stigma, depression, and suicidal status among people living with HIV / AIDS. 2018; 1–11.
[35] Bawo James, Adeola Adeyelu JRK. Are Persons Who Inject Drugs in Nigeria Accessing Evidence-Based Care? [Internet]. Natl. Inst. Drug use. 2021 p. 1. Available from:
[36] Budambula V, Matoka C, Ouma J, Ahmed AA, Otieno MF, Were T. Socio-demographic and sexual practices associated with HIV infection in Kenyan injection and non-injection drug users. BMC Public Health. 2018; 18.
[37] Noroozi M, Nedjat S, Golestan B, Majdzadeh R. What are differences between non-injecting and injecting drug addicts? Int J Prev Med. 2012; 3: 414–9.
[38] Sinha N. Effect on marital status on substance abuse - A review. Int J Recent Sci Res. 2018; 9: 27012–5.
[39] Ochonye B, Folayan MO, Fatusi AO, Emmanuel G, Adepoju O, Ajidagba B, et al. Satisfaction with use of public health and peer-led facilities for HIV prevention services by key populations in Nigeria. BMC Health Serv Res. 2019; 19.
[40] McCurdy SA, Ross MW, Williams ML, Kilonzo GP, Leshabari MT. Flashblood: Blood sharing among female injecting drug users in Tanzania. Addiction. 2010; 105: 1062–70.
[41] Rudolph AE, Davis WW, Quan VM, Ha T V., Minh NL, Gregowski A, et al. Perceptions of community- and family-level injection drug user (IDU)- and HIV-related stigma, disclosure decisions and experiences with layered stigma among HIV-positive IDUs in Vietnam. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2012; 24: 239–44.
[42] Khuat Thu Hong, Nguyen Thi Van Anh & JO. Understanding HIV and AIDS-related Stigma and Discrimination in Vietnam. 2004.
[43] Lim T, Zelaya C, Latkin C, Quan VM, Frangakis C, Ha TV, et al. Individual-level socioeconomic status and community-level inequality as determinants of stigma towards persons living with HIV who inject drugs in Thai Nguyen, Vietnam. J Int AIDS Soc. 2013; 16.
[44] World Bank. Gender-based violence: An analysis of the implications for the Nigeria for women project. Int Bank Reconstr Dev World Bank [Internet]. 2019; 1–48. Available from:
[45] Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller J, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med [Internet]. 2008; 66: 911–21.
[46] Olaiya O, Nerlander L, Mattson CL, Beer L. Exchange sex among people receiving medical care for HIV in the United States–medical monitoring project 2009–2013. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. 2018; 30: 1315–21.
[47] Tun W, Vu L, Adebajo SB, Abiodun L, Sheehy M, Karlyn A, et al. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria. Int J STD AIDS. 2013; 24: 619–25.
Cite This Article
  • APA Style

    Kalaiwo, A., Emmanuel, G., Sanni, O. F., Umoh, P., Abang, R., et al. (2024). Assessment of Stigma, Violence and Coping Mechanisms Among HIV Infected People Who Inject Drugs in Akwa-Ibom State, Nigeria. World Journal of Public Health, 9(2), 125-143. https://doi.org/10.11648/j.wjph.20240902.14

    Copy | Download

    ACS Style

    Kalaiwo, A.; Emmanuel, G.; Sanni, O. F.; Umoh, P.; Abang, R., et al. Assessment of Stigma, Violence and Coping Mechanisms Among HIV Infected People Who Inject Drugs in Akwa-Ibom State, Nigeria. World J. Public Health 2024, 9(2), 125-143. doi: 10.11648/j.wjph.20240902.14

    Copy | Download

    AMA Style

    Kalaiwo A, Emmanuel G, Sanni OF, Umoh P, Abang R, et al. Assessment of Stigma, Violence and Coping Mechanisms Among HIV Infected People Who Inject Drugs in Akwa-Ibom State, Nigeria. World J Public Health. 2024;9(2):125-143. doi: 10.11648/j.wjph.20240902.14

    Copy | Download

  • @article{10.11648/j.wjph.20240902.14,
      author = {Abiye Kalaiwo and Godwin Emmanuel and Olaniyi Felix Sanni and Paul Umoh and Roger Abang and Paul Amechi and Ochonye Bartholomew Boniface and Olugbemi Motilewa},
      title = {Assessment of Stigma, Violence and Coping Mechanisms Among HIV Infected People Who Inject Drugs in Akwa-Ibom State, Nigeria
    },
      journal = {World Journal of Public Health},
      volume = {9},
      number = {2},
      pages = {125-143},
      doi = {10.11648/j.wjph.20240902.14},
      url = {https://doi.org/10.11648/j.wjph.20240902.14},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.wjph.20240902.14},
      abstract = {People who inject drugs (PWIDs) living with HIV face high levels of stigma, violence, and rape due to their risky lifestyles, potentially facilitating the spread of HIV. This study assessed the level and type of stigma and violence among PWIDs attending Heartland Alliance in Akwa Ibom State and their coping mechanisms. This descriptive cross-sectional study of 442 PWIDs receiving care at four one-stop shops in the state was conducted using mixed methods. Quantitative data were collected through pretested structured questionnaires and an adopted stigma scale, administered by trained research assistants using Computer Assisted Personal Interviewer (CAPI). For qualitative data, one focus group discussion (FGD) was held at each site with 8-10 purposively selected PWIDs, and transcripts were analyzed thematically. The study findings reveals that most respondents were male (78%) with a mean age of 32.7±7 years. Pentazocine use was common (52%), and 18% shared needles, with 15% sharing blood after injections among friends. More than half (58%) missed more than one dose of ARVs in the past week. Perceived stigma (59%) was more common than internal stigma (18%), with predictors being student status, non-disclosure of HIV status, and non-adherence to treatment. PWIDs Physical violence (47.5%) and verbal abuse (37.1%) were prevalent among PWIDs. Female PWIDs had a ninefold higher risk of rape. Coping mechanisms included isolation, increased substance use, battle readiness, and positive reframing. Conclusion: PWIDs face significant levels of stigma, violence, and non-adherence, jeopardizing treatment outcomes and perpetuating STI, HIV, and blood-borne infection transmission. Establishing harm-reduction programs is essential to address these vulnerabilities and the consequences associated with drug use.
    },
     year = {2024}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Assessment of Stigma, Violence and Coping Mechanisms Among HIV Infected People Who Inject Drugs in Akwa-Ibom State, Nigeria
    
    AU  - Abiye Kalaiwo
    AU  - Godwin Emmanuel
    AU  - Olaniyi Felix Sanni
    AU  - Paul Umoh
    AU  - Roger Abang
    AU  - Paul Amechi
    AU  - Ochonye Bartholomew Boniface
    AU  - Olugbemi Motilewa
    Y1  - 2024/05/10
    PY  - 2024
    N1  - https://doi.org/10.11648/j.wjph.20240902.14
    DO  - 10.11648/j.wjph.20240902.14
    T2  - World Journal of Public Health
    JF  - World Journal of Public Health
    JO  - World Journal of Public Health
    SP  - 125
    EP  - 143
    PB  - Science Publishing Group
    SN  - 2637-6059
    UR  - https://doi.org/10.11648/j.wjph.20240902.14
    AB  - People who inject drugs (PWIDs) living with HIV face high levels of stigma, violence, and rape due to their risky lifestyles, potentially facilitating the spread of HIV. This study assessed the level and type of stigma and violence among PWIDs attending Heartland Alliance in Akwa Ibom State and their coping mechanisms. This descriptive cross-sectional study of 442 PWIDs receiving care at four one-stop shops in the state was conducted using mixed methods. Quantitative data were collected through pretested structured questionnaires and an adopted stigma scale, administered by trained research assistants using Computer Assisted Personal Interviewer (CAPI). For qualitative data, one focus group discussion (FGD) was held at each site with 8-10 purposively selected PWIDs, and transcripts were analyzed thematically. The study findings reveals that most respondents were male (78%) with a mean age of 32.7±7 years. Pentazocine use was common (52%), and 18% shared needles, with 15% sharing blood after injections among friends. More than half (58%) missed more than one dose of ARVs in the past week. Perceived stigma (59%) was more common than internal stigma (18%), with predictors being student status, non-disclosure of HIV status, and non-adherence to treatment. PWIDs Physical violence (47.5%) and verbal abuse (37.1%) were prevalent among PWIDs. Female PWIDs had a ninefold higher risk of rape. Coping mechanisms included isolation, increased substance use, battle readiness, and positive reframing. Conclusion: PWIDs face significant levels of stigma, violence, and non-adherence, jeopardizing treatment outcomes and perpetuating STI, HIV, and blood-borne infection transmission. Establishing harm-reduction programs is essential to address these vulnerabilities and the consequences associated with drug use.
    
    VL  - 9
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Sections